Ilaria Grassi - Concepedia

Author

Ilaria Grassi

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ORCID

Also Known As

Grassi, Ilaria, I Grassi, I. Grassi, Ilaria GRASSI, Ilaria Grassi, Irene Grassi, Maria Clara Chionsini

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Istituti di Ricovero e Cura a Carattere Scientifico University of Ferrara IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola Ospedale Santa Maria della Misericordia di Rovigo

About

Ilaria Grassi is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	338
2	Health Sciences	2	2	58
3	Biochemistry	1	1	145
4	Endocrinology	1	1	47
5	Gastroenterology	1	1	29

Ilaria Grassi

Publications

840

Citations

H-Index

Page 1

	Year	Citations
Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies Michel Meignan, Anne‐Ségolène Cottereau, Annibale Versari, Journal of Clinical Oncology	2016	325
The clinical use of PET with (11)C-acetate. Ilaria Grassi, Cristina Nanni, Vincenzo Allegri, PubMed Cardiovascular ToxicityOncologyBiochemistryC-acetate PetPharmacology	2012	145
Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin Alessandra Gambineri, Robert K. Semple, G Forlani, European Journal of Endocrinology	2008	60
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors Silvia Nicolini, Lisa Bodei, Alberto Bongiovanni, European Journal of Nuclear Medicine and Molecular Imaging Pancreatic CancerMedicineNeuroendocrine DisorderPathologyOncology	2021	57
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma Matt Lechner, Yoko Takahashi, Mario Turri–Zanoni, European Journal of Cancer Neuro-oncologyMedicinePathologyClinical OutcomesOlfactory Neuroblastoma	2021	49
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome Alessandra Gambineri, Andrea Repaci, Laura Patton, Nutrition Metabolism and Cardiovascular Diseases ObesityMetabolic SyndromeMetabolic DisorderCardiovascular DiseaseGynecology	2009	47
Usefulness of 64Cu-ATSM in Head and Neck Cancer Ilaria Grassi, Cristina Nanni, Gianfranco Cicoria, Clinical Nuclear Medicine	2013	42
Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT Egesta Lopci, Ilaria Grassi, Domenico Rubello, Clinical Nuclear Medicine	2015	36
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study Giovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, European Journal of Nuclear Medicine and Molecular Imaging Endocrine OncologySurgical Oncology10-Year Follow-upGastrointestinal OncologyMedicine	2020	29
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up Stefano Severi, Ilaria Grassi, Alberto Bongiovanni, Journal of Nuclear Medicine	2024	16

Page 1